| Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists |
Bruno... 'yrotsiH gnikaM' rof ésoR & agMKR... ’?no gniog si htrae no tahW‘ :Man... etu nelots ot deknil diar letoTMC... maeT ytraP-itluM nioJ oT toN nXRP... ?deneppah tahW .gnilur elppiRThe... ’esle gnihtyreve revo gninniwFil-Ams... dehsup nalp omanatnauG sa yrroI... 'yawa em welb eno dna kcots niXT.com... riaP gnidarT TDSU htiW )RAVI(Chinese... tnega ngierof sa tserra s'edia